Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MioPain: Methocarbamol/Paracetamol regimens in acute low back pain
NCT05204667Phase 4Terminated
- Sponsor
- Angelini Pharma
- Start
- Oct 2021
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methocarbamol, acetaminophen in low back pain (LBP), sponsored by Angelini Pharma. Started Oct 2021; status: terminated.
02
Drugs
methocarbamolacetaminophen
03
Conditions
low back pain (LBP)
Beyond the preview
Go deeper on NCT05204667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05204667.